It also hinges on FDA approval as well before being due and payable .... but ultimately if Smith & Nephew have bought Osiris, then they are actually a step closer to Mesoblast![]()
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
3.32%
!
$2.04
Cell Therapy News/Articles, page-343
-
Top Stories
- There are more pages in this discussion • 705 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.